Certain advocates believe that the Department of Health and Human Services (HHS) should amend Section 1557 of the Patient Protection and Affordability Act to include language that prohibits cost sharing and formulary decisions based on disease category. Recent pressure from both patient advocacy groups and manufacturers are claiming health plans and payers use copay tiers and formularies to dissuade patients from starting and maintaining therapy.

Do you believe this is a violation of patients’ Civil Rights?

Yes: 10%

No: 90%